# Amycretin oral phase 2 trial: HbA1c in type 2 diabetes

Source: https://pepvault.app/research/amycretin-mora-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Amycretin](https://pepvault.app/research#amycretin)

Randomized trial · people

# Amycretin: oral 50 mg arm cut HbA1c by 1.4% at 36 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In people with type 2 diabetes, an oral, once-daily form of amycretin lowered HbA1c more than placebo at all three doses tested, with gut side effects becoming more common at higher doses.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 186
- **Published:** 2026
- **Journal:** Lancet

## What they tested

The team tested how different doses of once-daily oral amycretin (zenagamtide), a single molecule that acts on GLP-1, amylin and calcitonin receptors, change blood sugar control and safety compared with placebo in type 2 diabetes.

## How the study was done

A randomized, double-blind, placebo-controlled, phase 2 dose-finding trial in 186 adults with type 2 diabetes already taking metformin, with or without an SGLT2 inhibitor, at 83 sites in 11 countries. Participants got 6, 25 or 50 mg of oral amycretin or a matching placebo (a dummy treatment) for 36 weeks, with doses stepped up from 1.5 mg every 4 weeks until each arm's target dose was reached.

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

HbA1c (a 3-month average of blood sugar) started at a mean of about 7.9% to 8.1%. By week 36 it fell by 0.9% in the 6 mg arm, 1.3% in the 25 mg arm and 1.4% in the 50 mg arm; compared with placebo, the differences were -0.5%, -0.99% and -1.09%, all statistically significant. Stomach and gut side effects were the most common, seen in 26% of the 6 mg arm, 41% of the 25 mg arm, 47% of the 50 mg arm and 23% of the placebo arm. Serious adverse events occurred in 7 participants, all taking amycretin (2, 2 and 3 across the dose arms), none on placebo, and nobody died.

## What it doesn’t show

This was a mid-stage trial lasting 36 weeks with only 30 people on placebo, so it can't show longer-term effects or rarer side effects. It only included people with type 2 diabetes on metformin, and it was funded by Novo Nordisk.

## The paper

Mora et al. Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial. Lancet. 2026.

- [PubMed (PMID 42532079)](https://pubmed.ncbi.nlm.nih.gov/42532079/)
- [The paper (DOI 10.1016/S0140-6736(26)01247-X)](https://doi.org/10.1016/S0140-6736%2826%2901247-X)
- [ClinicalTrials.gov (NCT06542874)](https://clinicaltrials.gov/study/NCT06542874)

## The compound

- [Amycretin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

## More studies on Amycretin

- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080) Randomized trial · people · 2026
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025) Randomized trial · people · 2025
- [Amycretin: side effects all mild or moderate in first human trial](https://pepvault.app/research/amycretin-gasiorek-2025) Randomized trial · people · 2025
- [Amycretin: similar drug exposure with kidney impairment in phase 1](https://pepvault.app/research/amycretin-oldenburg-2026) Clinical trial · people · 2026
- [Amycretin cut body weight by 18% in obese rats over 21 days](https://pepvault.app/research/amycretin-kuhre-2025) Animal study · mice and rats · 2025
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Amycretin

- [Amycretin: the full reference](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/amycretin-10mg)

### Studies

- [Amycretin: HbA1c fell up to 1.7% at 36 weeks in type 2 diabetes](https://pepvault.app/research/amycretin-mora-2026-42532080)
- [Amycretin: 24.3% weight loss at 36 weeks in a phase 1b/2a trial](https://pepvault.app/research/amycretin-dahl-2025)
- [All 6 studies](https://pepvault.app/research#amycretin)

### Compared with

- [CagriSema vs Amycretin](https://pepvault.app/peptides/compare/cagrisema-vs-amycretin)
- [Semaglutide vs Amycretin](https://pepvault.app/peptides/compare/semaglutide-vs-amycretin)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

<!--promo-->

PepVault for iPhone

## Taking amycretin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Amycretin](https://pepvault.app/research#amycretin)

## The library

- [Amycretin](https://pepvault.app/peptides/amycretin)
- [Amycretin dose guide](https://pepvault.app/lab/dosage/amycretin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
